Person-based co-design of a decision aid template for people with a genetic predisposition to cancer
Person-based co-design of a decision aid template for people with a genetic predisposition to cancer
Background: People with genetic predispositions to cancer are faced with complex health decisions about managing their risk. Decision aids can support informed, values-based decisions, alongside shared decision-making with a clinician. Whilst diagnoses of genetic predispositions to cancer are increasing, there is no scalable decision aid to support these people. This paper presents an accessible, relevant decision aid template which can be adapted for different predispositions to cancer. Methods: The decision aid template was co-developed with 12 patients affected by cancer and informed by empirical and theoretical literature. In addition, consultations were conducted with a further 19 people with Lynch syndrome; a specific genetic predisposition to cancer. Clinical stakeholders were consulted regularly. Coulter's framework for decision aid development guided the process, and these activities were complemented by the International Patient Decision Aid Standards, and the latest evidence on communicating risk in decision aids. Programme theory was developed to hypothesise how the decision aid would support decision-making and contextual factors which could influence the process. Guiding principles co-developed with the patient panel described how the decision aid could effectively engage people. Results: The in-depth co-design process led to the identification of five core components of an accessible decision aid template for people with a genetic predisposition to cancer: defining the decision; option grid showing implications of each option; optional further details such as icon arrays to show tailored risk and personal narratives; values clarification activity; and a summary to facilitate discussion with a clinician. Specific guidance was produced describing how to develop each component. The guiding principles identified that the decision aid template needed to promote trust, reduce distress, and be comprehensive, personally relevant and accessible in order to engage people. Conclusion: Adopting a co-design process helped ensure that the decision aid components were relevant and accessible to the target population. The template could have widespread application through being adapted for different genetic predispositions. The exact content should be co-designed with people from diverse backgrounds with lived experience of the specific predisposition to ensure it is as useful, engaging and relevant as possible.
cancer, decision aid (DA), genetic predisposition, patient and public involvement (PPI), person-based approach, template
Morton, Kate
6fa41cd3-ba4d-476c-9020-b8ef93c7ade7
Kohut, Kelly
62c06d25-2359-4a2a-a155-a54a8937fd8b
Turner, Lesley
28a850ba-802d-45db-9245-08e31e7742c4
Smith, Sian
f003c78f-69b9-4578-a1a9-26f94ea80a11
Crosbie, Emma J.
ee31bba5-659e-4165-a707-aaee00f040e0
Ryan, Neil
d31f504f-df63-4aba-8bac-8cf823e3b4ed
Grimmett, Chloe
7f27e85b-2850-481d-a7dd-2835e1a925cd
Eccles, Diana M.
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
Foster, Claire
00786ac1-bd47-4aeb-a0e2-40e058695b73
CanGene CanVar Patient Reference Panel
LDAS (International Lynch Decision Aid Stakeholder Panel)
23 November 2022
Morton, Kate
6fa41cd3-ba4d-476c-9020-b8ef93c7ade7
Kohut, Kelly
62c06d25-2359-4a2a-a155-a54a8937fd8b
Turner, Lesley
28a850ba-802d-45db-9245-08e31e7742c4
Smith, Sian
f003c78f-69b9-4578-a1a9-26f94ea80a11
Crosbie, Emma J.
ee31bba5-659e-4165-a707-aaee00f040e0
Ryan, Neil
d31f504f-df63-4aba-8bac-8cf823e3b4ed
Grimmett, Chloe
7f27e85b-2850-481d-a7dd-2835e1a925cd
Eccles, Diana M.
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
Foster, Claire
00786ac1-bd47-4aeb-a0e2-40e058695b73
Morton, Kate, Kohut, Kelly, Turner, Lesley, Smith, Sian, Crosbie, Emma J., Ryan, Neil, Grimmett, Chloe, Eccles, Diana M. and Foster, Claire
,
CanGene CanVar Patient Reference Panel and LDAS (International Lynch Decision Aid Stakeholder Panel)
(2022)
Person-based co-design of a decision aid template for people with a genetic predisposition to cancer.
Frontiers in Digital Health, 4, [1039701].
(doi:10.3389/fdgth.2022.1039701).
Abstract
Background: People with genetic predispositions to cancer are faced with complex health decisions about managing their risk. Decision aids can support informed, values-based decisions, alongside shared decision-making with a clinician. Whilst diagnoses of genetic predispositions to cancer are increasing, there is no scalable decision aid to support these people. This paper presents an accessible, relevant decision aid template which can be adapted for different predispositions to cancer. Methods: The decision aid template was co-developed with 12 patients affected by cancer and informed by empirical and theoretical literature. In addition, consultations were conducted with a further 19 people with Lynch syndrome; a specific genetic predisposition to cancer. Clinical stakeholders were consulted regularly. Coulter's framework for decision aid development guided the process, and these activities were complemented by the International Patient Decision Aid Standards, and the latest evidence on communicating risk in decision aids. Programme theory was developed to hypothesise how the decision aid would support decision-making and contextual factors which could influence the process. Guiding principles co-developed with the patient panel described how the decision aid could effectively engage people. Results: The in-depth co-design process led to the identification of five core components of an accessible decision aid template for people with a genetic predisposition to cancer: defining the decision; option grid showing implications of each option; optional further details such as icon arrays to show tailored risk and personal narratives; values clarification activity; and a summary to facilitate discussion with a clinician. Specific guidance was produced describing how to develop each component. The guiding principles identified that the decision aid template needed to promote trust, reduce distress, and be comprehensive, personally relevant and accessible in order to engage people. Conclusion: Adopting a co-design process helped ensure that the decision aid components were relevant and accessible to the target population. The template could have widespread application through being adapted for different genetic predispositions. The exact content should be co-designed with people from diverse backgrounds with lived experience of the specific predisposition to ensure it is as useful, engaging and relevant as possible.
Text
Decision aid planning paper 23.11.22 accepted version
- Accepted Manuscript
Text
fdgth-04-1039701
- Version of Record
More information
Accepted/In Press date: 28 October 2022
Published date: 23 November 2022
Additional Information:
© 2022 Morton, Kohut, Turner, Smith, Crosbie, Ryan, Grimmett, Eccles and Foster, The CanGene CanVar Patient Reference Panel, The International Lynch Decision Aid Stakeholder (LDAS) Panel.
Keywords:
cancer, decision aid (DA), genetic predisposition, patient and public involvement (PPI), person-based approach, template
Identifiers
Local EPrints ID: 473251
URI: http://eprints.soton.ac.uk/id/eprint/473251
PURE UUID: 27bde5ad-941c-401c-a5eb-934df6755f11
Catalogue record
Date deposited: 12 Jan 2023 18:23
Last modified: 21 Sep 2024 01:49
Export record
Altmetrics
Contributors
Author:
Kelly Kohut
Author:
Lesley Turner
Author:
Sian Smith
Author:
Emma J. Crosbie
Author:
Neil Ryan
Corporate Author: CanGene CanVar Patient Reference Panel
Corporate Author: LDAS (International Lynch Decision Aid Stakeholder Panel)
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics